IL161495A0 - A packaging cell containing nucleic acid constructs and methods for packaging a viral vector - Google Patents

A packaging cell containing nucleic acid constructs and methods for packaging a viral vector

Info

Publication number
IL161495A0
IL161495A0 IL16149502A IL16149502A IL161495A0 IL 161495 A0 IL161495 A0 IL 161495A0 IL 16149502 A IL16149502 A IL 16149502A IL 16149502 A IL16149502 A IL 16149502A IL 161495 A0 IL161495 A0 IL 161495A0
Authority
IL
Israel
Prior art keywords
packaging
methods
nucleic acid
viral vector
cell containing
Prior art date
Application number
IL16149502A
Other languages
English (en)
Original Assignee
Virxsys Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Virxsys Corp filed Critical Virxsys Corp
Publication of IL161495A0 publication Critical patent/IL161495A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/635—Externally inducible repressor mediated regulation of gene expression, e.g. tetR inducible by tetracyline
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16051—Methods of production or purification of viral material
    • C12N2740/16052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL16149502A 2001-10-30 2002-10-30 A packaging cell containing nucleic acid constructs and methods for packaging a viral vector IL161495A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/020,472 US6835568B2 (en) 2001-10-30 2001-10-30 Regulated nucleic acid expression system
PCT/US2002/034932 WO2003054210A2 (en) 2001-10-30 2002-10-30 Regulated nucleic acid expression system

Publications (1)

Publication Number Publication Date
IL161495A0 true IL161495A0 (en) 2004-09-27

Family

ID=21798805

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16149502A IL161495A0 (en) 2001-10-30 2002-10-30 A packaging cell containing nucleic acid constructs and methods for packaging a viral vector
IL161495A IL161495A (en) 2001-10-30 2004-04-19 Packaging cell containing nucleic acid constructs and methods for packaging a viral vector

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL161495A IL161495A (en) 2001-10-30 2004-04-19 Packaging cell containing nucleic acid constructs and methods for packaging a viral vector

Country Status (15)

Country Link
US (2) US6835568B2 (xx)
EP (1) EP1446488A4 (xx)
JP (1) JP2005512573A (xx)
KR (1) KR100984268B1 (xx)
CN (1) CN100591769C (xx)
AU (1) AU2002365090B2 (xx)
BR (1) BR0213964A (xx)
CA (1) CA2464268C (xx)
CZ (1) CZ2004546A3 (xx)
IL (2) IL161495A0 (xx)
MX (1) MXPA04003969A (xx)
NO (1) NO20041763L (xx)
NZ (1) NZ533132A (xx)
RU (1) RU2004116319A (xx)
WO (1) WO2003054210A2 (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7297536B2 (en) * 2003-01-23 2007-11-20 Wisconsin Alumni Research Foundation Inducible protein expression system
US20090123494A1 (en) * 2007-07-31 2009-05-14 William Staplin Momlv-based pseudovirion packaging cell line
AU2009228183A1 (en) * 2008-03-28 2009-10-01 Virxsys Corporation Lentivirus-based immunogenic vectors
CA2780671A1 (en) * 2009-11-05 2011-05-12 Proyecto De Biomedicina Cima, S.L. Regulated expression system
US20130189754A1 (en) 2011-09-12 2013-07-25 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
US9402894B2 (en) 2011-10-27 2016-08-02 International Aids Vaccine Initiative Viral particles derived from an enveloped virus
US9347065B2 (en) 2012-03-29 2016-05-24 International Aids Vaccine Initiative Methods to improve vector expression and genetic stability
RU2749717C2 (ru) * 2015-11-24 2021-06-16 Глэксосмитклайн Интеллекчуал Проперти Дивелопмент Лимитед Способ временной трансфекции для продуцирования ретровируса
CA3006288A1 (en) * 2015-11-24 2017-06-01 Glaxosmithkline Intellectual Property Development Limited Stable cell lines for retroviral production
AU2018356538B2 (en) * 2017-10-25 2023-09-28 Nouscom Ag Eukaryotic cell line

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2140380T5 (es) 1990-03-21 2005-03-16 Geneart Gmbh Secuencias de adn que codifican polipeptidos gag retroviricos modificados y vacunas que las contienen o agregados de las mismas.
US6174666B1 (en) * 1992-03-27 2001-01-16 The United States Of America As Represented By The Department Of Health And Human Services Method of eliminating inhibitory/instability regions from mRNA
US5750396A (en) * 1995-05-08 1998-05-12 St. Judes Children's Research Hospital Stable virus packaging cell lines
US5885806A (en) * 1995-11-28 1999-03-23 The Johns Hopkins University School Of Medicine Methods to prepare conditionally replicating viral vectors
US5888767A (en) * 1996-11-27 1999-03-30 The Johns Hopkins University School Of Medicine Method of using a conditionally replicating viral vector to express a gene
US6133027A (en) * 1996-08-07 2000-10-17 City Of Hope Inducible expression system
GB9803351D0 (en) 1998-02-17 1998-04-15 Oxford Biomedica Ltd Anti-viral vectors
HUP0201019A2 (en) 1999-04-26 2002-08-28 Leuven K U Res & Dev Synthetic gene for expressing active retroviral protein in eukaryotes

Also Published As

Publication number Publication date
MXPA04003969A (es) 2004-07-08
BR0213964A (pt) 2006-05-30
IL161495A (en) 2009-06-15
CZ2004546A3 (cs) 2004-10-13
WO2003054210B1 (en) 2004-02-26
US20060121579A1 (en) 2006-06-08
RU2004116319A (ru) 2005-03-27
KR20040066799A (ko) 2004-07-27
CN1578837A (zh) 2005-02-09
EP1446488A2 (en) 2004-08-18
JP2005512573A (ja) 2005-05-12
EP1446488A4 (en) 2004-12-22
NO20041763L (no) 2004-04-29
KR100984268B1 (ko) 2010-09-30
CA2464268C (en) 2012-03-20
AU2002365090A1 (en) 2003-07-09
CN100591769C (zh) 2010-02-24
WO2003054210A3 (en) 2003-12-24
US8043611B2 (en) 2011-10-25
WO2003054210A2 (en) 2003-07-03
US20030087419A1 (en) 2003-05-08
US6835568B2 (en) 2004-12-28
AU2002365090B2 (en) 2007-12-20
NZ533132A (en) 2008-04-30
CA2464268A1 (en) 2003-07-03

Similar Documents

Publication Publication Date Title
EP1170363A4 (en) VIRAL ENVELOPE VECTOR FOR GENE TRANSFER
IL154599A0 (en) Methods for transduction of cells with viral vectors
IL163546A0 (en) An influenza viral vector containing incorporationsequences
EP1436429A4 (en) TARGETED RECOMBINANT PRODUCTS OF NUCLEIC ACIDS AND USES RELATING THERETO
EP1403942A4 (en) CELL AND CELL PACK
AU1410399A (en) Nucleic acid transfer vector for the introduction of nucleic acid into the dna of a cell
HK1052140A1 (zh) 將基因導入腎細胞的病毒媒介動物
EP1335437A4 (en) PACKAGING CONTAINER FOR TRANSPORTING ACCUMULATORS
HUP0202221A1 (en) Tenascin-c nucleic acid lagands
IL161495A0 (en) A packaging cell containing nucleic acid constructs and methods for packaging a viral vector
EP1005561A4 (en) VECTOR, VIRAL VECTORS AND PACKAGING CELL LINES TO THEIR REPRODUCTION
IL162274A0 (en) A nucleic acid and protein designated 193p1e1b andcompositions containing the same
HK1073669A1 (en) Nucleic acid constructs for gene expression
AU2002358273A8 (en) Nucleic acid-associated proteins
HUP0203848A3 (en) Nucleic acid vaccination
EP1250156A4 (en) METHOD FOR TRANSFECTING NUCLEIC ACID IN CELLS
AU2002360704A1 (en) Connector for use in packaging aerosol containers
GB0021008D0 (en) Protein and nucleic acid sequence
IL162207A0 (en) Nucleic acid labeling by thermoanaerocter thermohydrosulfuricus dna polymeasei variants
AU2002326372A1 (en) Nucleic acid-associated proteins
GB0016124D0 (en) Chemistry reaction station and reaction vessel therefor
AU2002364926A8 (en) Nucleic acid-associated proteins
EP1380647A4 (en) DEOXYMUGINEIC ACID SYNTHASE AND GENE THEREOF
AU2002326332A1 (en) Nucleic acid-associated proteins
AU2002338706A1 (en) Nucleic acid for cloning vector